Medline Inc.
NASDAQ:MDLN · NASDAQ Global Select
-$0.42 today
Vol 13.95M · Avg 9.27M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $2.2B |
| Receivables | $3.7B |
| Inventory | $4.8B |
| Other Current | $463.0M |
| Total Current Assets | $11.2B |
| PP&E (Net) | $4.8B |
| Goodwill | $8.1B |
| Intangible Assets | $13.7B |
| Tax Assets | $837.0M |
| Other Non-current | $446.0M |
| Total Non-current Assets | $27.8B |
| Total Assets | $39.0B |
Analysis
Selected assets total $39.0B for Latest. The largest visible component is Intangible Assets at $13.7B, about 35.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 3 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.9B +675.6% | $250.0M -84.2% | $1.6B | $1.3B | $1.2B | $1.0B |
| Short-term Investments | $0 | $0 | $0 | $1.4B | -$1.7B | -$1.6B |
| Net Receivables | $3.5B +9.8% | $3.2B +8.8% | $3.0B | $802.6M | $668.2M | $533.8M |
| Inventory | $4.8B +7.0% | $4.5B +16.9% | $3.8B | $664.0M | $652.8M | $641.6M |
| Other Current Assets | $438.0M +26.2% | $347.0M -23.1% | $451.0M | $776.0M | -$1.7B | $1.5B |
| Total Current Assets | $10.7B +29.1% | $8.3B -6.1% | $8.8B | $5.6B | $3.6B | $12.5B |
| Property, Plant & Equipment (Net) | $4.8B -4.0% | $5.0B +3.8% | $4.8B | $1.4B | $575.8M | $1.2B |
| Goodwill | $8.1B +0.2% | $8.1B +7.1% | $7.5B | -$1.5B | $1.4B | $925.8M |
| Intangible Assets | $13.9B -4.6% | $14.6B -1.5% | $14.8B | $1.1B | $1.4B | $568.8M |
| Long-term Investments | $0 -100.0% | $48.0M -44.2% | $86.0M | $490.4M | $1.2B | $524.0M |
| Tax Assets | $0 | $0 | $0 | $375.6M | $364.4M | $1.5B |
| Other Non-current Assets | $1.1B +1818.2% | $55.0M -50.0% | $110.0M | $365.8M | $1.4B | $1.4B |
| Total Non-current Assets | $27.8B +0.4% | $27.7B +1.4% | $27.3B | $5.2B | $4.7B | -$15.3B |
| Total Assets | $38.5B +7.0% | $36.0B -0.4% | $36.1B | -$16.0B | $14.6B | $13.3B |
| Account Payables | $961.0M +10.6% | $869.0M +24.9% | $696.0M | $991.6M | $1.2B | $1.3B |
| Short-term Debt | $77.0M -50.0% | $154.0M +26.2% | $122.0M | $1.1B | $1.2B | -$1.6B |
| Tax Payables | $0 | $0 | $0 | $843.2M | $708.8M | $574.4M |
| Deferred Revenue | $0 | $0 | $0 | -$1.6B | $340.6M | -$1.6B |
| Other Current Liabilities | $0 -100.0% | $1.1B +11.4% | $972.0M | $1.3B | $650.0M | $1.1B |
| Total Current Liabilities | $2.5B +2.0% | $2.4B +14.5% | $2.1B | $8.7B | $12.8B | $6.0B |
| Long-term Debt | $12.5B -24.0% | $16.4B -0.2% | $16.4B | $1.1B | $483.4M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $1.3B | $1.2B | $746.6M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $503.0M | $1.0B | -$1.6B |
| Other Non-current Liabilities | $4.2B +1470.3% | $269.0M -12.7% | $308.0M | $869.8M | $1.2B | $489.0M |
| Total Non-current Liabilities | $16.7B -1.8% | $17.0B +0.0% | $17.0B | $4.7B | $11.3B | $3.9B |
| Total Liabilities | $19.2B -1.3% | $19.5B +1.6% | $19.1B | $5.9B | $8.8B | $14.7B |
| Common Stock | $0 -100.0% | $16.1B -2.5% | $16.6B | $920.2M | $785.8M | $651.4M |
| Retained Earnings | -$7.0M | $0 | $0 | $743.8M | $1.0B | -$1.6B |
| Accumulated OCI | $27.0M +145.5% | $11.0M -94.1% | $188.0M | $1.5B | -$1.6B | $393.8M |
| Other Stockholders Equity | $0 | $0 | $0 | $620.6M | $486.2M | $351.8M |
| Minority Interest | $8.5B | $0 | $0 | -$1.7B | $853.0M | $1.4B |
| Total Equity | $19.3B +16.7% | $16.5B -2.7% | $17.0B | $11.8B | $10.4B | $9.1B |
| Total Debt | $12.6B -25.7% | $16.9B +0.4% | $16.8B | $746.6M | $735.4M | $724.2M |
| Net Debt | $10.6B -36.2% | $16.6B +9.2% | $15.2B | $468.0M | -$1.7B | $389.6M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
ResMed Inc.
NYSE:RMD
$27.26B
The Cooper Companies, Inc.
NASDAQ:COO
$12.85B
Avantor, Inc.
NYSE:AVTR
$6.54B
Bausch + Lomb Corporation
NYSE:BLCO
$5.32B
Netskope, Inc. Class A Common Stock
NASDAQ:NTSK
$3.61B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.13B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.17B
Lumexa Imaging Holdings, Inc. Common Stock
LMRI
$887.79M
InfuSystem Holdings, Inc.
AMEX:INFU
$186.28M
Black Rock Coffee Bar, Inc. Class A Common Stock
NASDAQ:BRCB
$136.95M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does MDLN have?
Medline Inc. (MDLN) reported $1.94B in cash and equivalents in fiscal 2025.
How much debt does MDLN carry?
Medline Inc. (MDLN) reported $12.56B of total debt, with net debt of $10.62B.
Explore More
Continue the stock analysis
Jump to another research area for this company.